Introduction {#Sec1}
============

Bone remodeling is a dynamic, life-long process in which bone formation by osteoblasts and bone resorption by osteoclasts are balanced to maintain a steady state. Osteoclasts are multinucleated resorptive cells of bone \[[@CR1]\] that contribute to the maintenance of bone homeostasis. Osteoclasts are formed by fusion of monocyte/macrophage lineage precursor cells under the control of macrophage colony stimulating factor (M-CSF), which regulates the survival and proliferation of precursors \[[@CR2]\], and by receptor activator of nuclear factor-kappa B ligand (RANKL), which promotes osteoclast differentiation and bone resorptive activity \[[@CR3]--[@CR5]\].

During osteoclastogenesis, the tight control of actin filament organization is crucial for cell formation, fusion, and differentiation and for cell attachment to bone surfaces. Notably, there are two structures in osteoclasts that are enriched with actin filaments: podosomes and sealing zones \[[@CR6]\]. In early stages of osteoclastogenesis, podosomes are organized as clusters, which associate into actin rings that eventually form belts at the osteoclast periphery. Sealing zones form when osteoclasts adhere to mineralized bone surfaces, after which bone resorption is initiated \[[@CR6], [@CR7]\]. The organization and maintenance of these structures in osteoclasts is very dependent on the appropriate formation of actin filaments, which in turn requires temporally and spatially appropriate activities of actin-binding proteins.

There are hundreds of actin-binding proteins, which include the gelsolin family of actin-severing and actin-capping proteins that contribute to actin filament remodeling in a calcium-dependent manner \[[@CR8], [@CR9]\]. Gelsolin is involved in osteoclast function since compared to wild type, gelsolin-deficient mice exhibit increased bone mass and bone strength and defective podosome assembly in osteoclasts \[[@CR10]\]. During osteoclastogenesis, gelsolin expression levels are relatively constant, while in cultured cells the expression of the gelsolin family protein adseverin is dramatically increased \[[@CR11]\]. More recent data indicate that adseverin is important in osteoclastogenesis and may be an essential regulator of osteoclastic activity \[[@CR11]--[@CR13]\].

Adseverin (also known as scinderin) is an actin-severing/capping protein that has been studied in depth in chromaffin cells of the adrenal medulla \[[@CR14]\]. The severing function of adseverin helps control actin filament length, while the actin-capping function of adseverin stabilizes actin filaments. Adseverin is highly expressed in many types of secretory cells, platelets \[[@CR15]\], chondrocytes \[[@CR16]\], odontoblasts \[[@CR17]\], and differentiating osteoclasts \[[@CR18]\]. Adseverin stimulates osteoclast differentiation and cell--cell fusion in cultured cells; the expression of adseverin is also increased in RANKL-induced osteoclastogenesis \[[@CR11]--[@CR13]\]. Adseverin knockdown inhibits bone resorption, reduces the secretion of TRAcP and cathepsin K, and alters actin filament organization \[[@CR11], [@CR13]\]. The increased expression of adseverin in osteoclastogenesis is dependent on the nuclear factor-kappa B (NF-κB) signaling pathway and on the expression of the osteoclastogenic transcription factor NFATc1 \[[@CR13]\]. Adseverin co-localizes with actin filaments in podosomes; in adseverin knockout mice, osteoclasts exhibit lower number of podosome belts \[[@CR12]\]. While these data suggest an important role for adseverin in osteoclastogenesis in vitro, it is not known whether adseverin impacts bone structure in healthy animals.

Here we examined bones from adseverin conditional null mice and background-matched wild-type mice by light microscopy, dual-energy X-ray absorptiometry (DEXA), and transmission electron microscopy (TEM). Since osteoclast function may differ in different skeletal sites \[[@CR19]--[@CR21]\], we compared osteoclast structure in alveolar bone with long bone and in healthy and inflamed sites.

Methods and Materials {#Sec2}
=====================

Adseverin Knockout Mouse Model {#Sec3}
------------------------------

All animal experiments were carried out in accordance with the Guide for the Humane Use and Care of Laboratory Animals and were approved by the University of Toronto Animal Care Committee. The generation of adseverin conditional knockout (adseverin KO) mice is described elsewhere \[[@CR12]\]. In brief, mice harboring the conditional allele of adseverin were obtained by creation of a targeting vector that interrupted the expression of adseverin. After introduction of the targeting construct, LoxP floxed adseverin C57BL/6 mice were crossed with TRAcP-Cre C57 mice (from Christine M. Hachfeld, Mayo Clinic, Rochester, MN). The male mice generated by this breeding were further back-crossed with the pure LoxP floxed adseverin females. Littermates that did not express TRAcP-Cre are designated here as wild type (WT). The effectiveness of the knockout was confirmed by expression of TRAcP-Cre and LoxP by PCR. The primers that were used to genotype the adseverin mice were as follows: Cre expression: Forward: 5′-GAGTGATGAGGTTCGCAAGA-3′; Reverse: 5′-CTACACCAGAGACGGAAATC-3′; Product size: 635 bp. Distal LoxP: SCAD3: 5′-GTTAGTATTCCTCACTGGCACCC-3′; Ads-SDL2: 5′ ATGTTTCAGGACAGGAGTCTGAGC-3′; Presence of the distal LoxP: 363 bp; Wild-type adseverin allele: 289 bp. Around the left upper first molar, inflammation was induced by bacteria ligature in both WT and adseverin KO mice to compare the phenotype of that in the right part of the same mouse.

Dual-Energy X-ray Absorptiometry {#Sec4}
--------------------------------

DEXA was performed on 3-month-old mice after CO~2~ asphyxiation, using an animal PIXImus densitometer (Lunar; GE). Data for bone mineral density (BMD) and bone mineral content (BMC) were collected for the lumbar vertebrae, right femur, and the entire skeleton after masking of the heads by a single operator.

TRAcP Staining and Image Analysis {#Sec5}
---------------------------------

Distal tibia were removed, fixed with 4% paraformaldehyde (PFA), and decalcified in 10% EDTA (pH 7.4) at 4 °C for 2 weeks. After dehydration, the samples were embedded in paraffin and sectioned (5 µm thick). TRAcP staining was performed to assess the presence of osteoclasts. Osteoclasts were visualized with a Nikon Eclipse E1000 microscope and images were obtained with a Hamamatsu ORCA-ER camera and processed using Simple PCI software (Version 5.2.1.1609; Compix Inc). Osteoclasts were recognized as TRAcP^+^ cells and the number of osteoclasts was counted relative to the bone surface, according to standardized histomorphometric methods \[[@CR22]\].

Transmission Electron Microscopy {#Sec6}
--------------------------------

At 2 months of age, WT and adseverin KO mice were sacrificed. Mice were perfused with fixative (1% glutaraldehyde + 4% formaldehyde in 0.1 M sodium cacodylate buffer). Maxillae and long bones were collected and fixed in the same fixative. After decalcification in EDTA (pH = 7.2) for 14 days at room temperature, specimens were post-fixed with 1% OsO~4~ for 1 h. After subsequent washing in buffer, samples were dehydrated by an ethanol series. Specimens were embedded in epoxy resin (LX112). Resin-embedded specimens were trimmed and 1-µm thin sections were cut. Sections were stained with Richardson's solution for light microscopic analysis (Leica DMRA). Image-Pro plus software (Media Cybernetics, Silver Spring, MD) was used to assess the size of osteoclasts.

After examining the sections by light microscopy, sites of interest were selected and ultrathin sections (80 nm) were cut with a diamond knife. The ultrathin sections were collected on Formvar-coated copper grids and counterstained with uranyl acetate and lead citrate. Micrographs were obtained with a Philips CM10 electron microscope. Size measurement of osteoclasts/nuclei/cytoplasm area was assessed by Image-Pro plus software (Media Cybernetics, Silver Spring, MD). Osteoclasts with ≥1 nucleus were used for analysis. Stereological analysis was performed according to Weibel et al. \[[@CR23]\].

Statistical Analysis {#Sec7}
--------------------

Results were shown as mean ± SD. Each experiment had a sample size of *n* ≥ 3, unless otherwise stated. Mean of the measurements of each osteoclast/nuclei/cytoplasm was calculated per mouse and pooled to compare the difference between WT and adseverin KO. Statistical analysis was performed using GraphPad Prism (version 5.0; GraphPad Software, LaJolla, CA). Student's *t* test was used to compare the data between WT and KO. Statistical significance was set at *p* \< 0.05.

Results {#Sec8}
=======

Osteoclast Number and Bone Resorption {#Sec9}
-------------------------------------

The effectiveness of conditional knockout of adseverin was confirmed by PCR (Fig. [1](#Fig1){ref-type="fig"}a). The role of adseverin in bone resorption in vivo is not well defined: previous micro-CT data showed no difference of bone structure between normal WT and adseverin KO mice \[[@CR12]\], while in the same study adseverin null mice were protected from inflammation-mediated bone loss. To determine whether osteoclasts and their resorptive activity are dependent on adseverin, we analyzed TRAcP^+^ osteoclasts in long bones of WT and adseverin KO mice (Fig. [1](#Fig1){ref-type="fig"}c, d). The number of TRAcP^+^ osteoclasts per bone surface was not different between the two genotypes (Fig. [1](#Fig1){ref-type="fig"}b). DEXA analysis showed no difference of bone mineral density or bone mineral content of the whole body, vertebrae, or femurs between adseverin KO and WT mice at 3 months of age (Table [1](#Tab1){ref-type="table"}). These data indicate that adseverin is not required for normal bone formation and remodeling.

Fig. 1The number of osteoclasts in vivo was not changed by knocking out adseverin. **a** Mice were genotyped using PCR to test the effectiveness by determining TRAcP-Cre (635 bp), distal floxed Ads product (363 bp) as well as wild-type mouse Ads amplicon (289 bp). **b** No significant difference of osteoclast number per bone surface was found (*p* = 0.7441). **c, d** TRAcP-stained sections of distal tibiae were analyzed and TRAcP^+^ cells (*arrow*) were shown in WT (**c**) and adseverin KO (**d**) samples. *Scale bar* 50 µm

Table 1DEXA analysis of BMC and BMD of WT and adseverin KO miceSamplesParametersWTAdseverin KO*p* value3 months old (*n* = 6)Whole body BMC (g)0.391 ± 0.0100.338 ± 0.0200.060Whole body BMD (g/cm^2^)0.060 ± 0.0020.056 ± 0.0010.069Vertebrae BMC (g)0.053 ± 0.0010.044 ± 0.0060.163Vertebrae BMD (g/cm^2^)0.060 ± 0.0010.054 ± 0.0040.261Femur BMC (g)0.017 ± 0.0010.016 ± 0.0010.776Femur BMD (g/cm^2^)0.066 ± 0.0030.066 ± 0.0030.877No significant difference was found between WT and adseverin KO mice by DEXA analysisBone mineral content (BMC) and bone mineral density (BMD) were collected from the lumbar vertebrae, right femur, and the entire skeleton after masking of the heads*p* values were calculated by *t* tests and data were shown as mean ± SD*p* \< 0.05 was considered statistically significant

Osteoclast Morphology {#Sec10}
---------------------

### Alveolar Bone {#Sec11}

Osteoclasts on the surface of the alveolar bone proper, and those located adjacent to the periodontal ligament, exhibited multiple nuclei and numerous mitochondria (Fig. [2](#Fig2){ref-type="fig"}). These features were similar for WT (Fig. [2](#Fig2){ref-type="fig"}a, c) and adseverin KO mice (Fig. [2](#Fig2){ref-type="fig"}b, d). In some samples in which silk ligatures were wrapped around the circumference of molar teeth to induce gingival inflammation, there were osteoclasts on the surface of the adjacent alveolar bone but there were no obvious differences of osteoclast structure between genotypes (Fig. [2](#Fig2){ref-type="fig"}c, d). Although there were abundant large osteoclasts on bone surfaces adjacent to inflamed gingival tissues, because of the low number of osteoclasts, we could not conduct meaningful statistical analysis of cell size.

Fig. 2Morphology of osteoclasts in molar. Osteoclasts adjacent to the alveolar bone of molars were visualized by TEM and compared between WT and adseverin KO mice. **a** Normal condition (without ligature) in WT mice. **b** Normal condition in adseverin KO mice. **c** Inflammatory condition (induced with ligature around molar) in WT mice. **d** Inflammatory condition in adseverin KO mice. Osteoclasts are *encircled* with a *dashed line. N* nucleus. *Scale bar* 5 µm

### Long Bone {#Sec12}

We found large numbers of osteoclasts on bone and calcified cartilage surfaces adjacent to the growth plate of tibiae in WT and KO mice (Fig. [3](#Fig3){ref-type="fig"}a--d; see also Fig. [1](#Fig1){ref-type="fig"}). Most osteoclasts were found at the junction of the growth plate cartilage and trabecular bone and were always in close vicinity to blood vessel capillaries. There were no obvious ultrastructural differences between osteoclasts from WT mice and KO mice (Fig. [3](#Fig3){ref-type="fig"}e, f). Osteoclasts in WT and adseverin KO mice were tightly adherent to the bone surface and exhibited well-developed sealing zones and ruffled borders.

Fig. 3Morphology of osteoclasts in long bone. **a--d** Morphology of osteoclasts as observed by light microscopy. Relatively high numbers of osteoclasts were found in the growth plate area in both WT (**a, c**) and adseverin KO (**b, d**) mice. *Arrows* point to osteoclasts. *Scale bar* 20 µm. **e, f** Morphology of osteoclasts visualized by TEM. *Scale bar* 5 µm. Osteoclasts are *encircled* with a *dashed line. N* nucleus, *B* bone, *RB* ruffled border, *FSD* functional secretory domain, *OC* osteoclast, *CC* chondrocyte, *CV* capillary vessel, *TB* trabecular bone

### Ruffled Borders {#Sec13}

As adseverin may be important for podosome structure and bone resorption in vitro \[[@CR12]\], we examined ruffled borders in detail. Ruffled borders were well developed in osteoclasts of both genotypes and were readily apparent in alveolar bone (Fig. [4](#Fig4){ref-type="fig"}a--d) and long bone (Fig. [4](#Fig4){ref-type="fig"}e, f) of WT and KO mice. There were no obvious morphological differences between the genotypes. Experimentally induced inflammation did not affect the formation of ruffled borders in WT (Fig. [4](#Fig4){ref-type="fig"}c) or adseverin KO mice (Fig. [4](#Fig4){ref-type="fig"}d). At healthy and inflamed sites, ruffled borders exhibited long, finger-like extensions (about 2 µm long, 100--200 nm wide) and were enriched with vacuoles that are important in exocytosis and endocytosis in bone resorption \[[@CR24]\].

Fig. 4Osteoclasts of adseverin KO mice form a normal ruffled border. **a** Ruffled border of an osteoclast from molar in control condition in WT. **b** Ruffled border of an osteoclast from molar in control condition in adseverin KO mice. **c** Ruffled border of an osteoclast from molar in inflammatory condition in WT mice. **d** Ruffled border of an osteoclast from molar in inflammatory condition in adseverin KO mice. **e** Ruffled border of an osteoclast from long bone in WT. **f** Ruffled border of an osteoclast from long bone in adseverin KO mice. *Arrows* point to the ruffled border. *OC* osteoclast, *B* bone. *Scale bar* 1 µm

### Sealing Zones {#Sec14}

Sealing zones were prominent in osteoclasts of WT and adseverin KO mice (Fig. [5](#Fig5){ref-type="fig"}a, b). The numbers of osteoclasts associated with bone surface were not different between the two genotypes (*p* = 0.25), indicating that adseverin does not contribute to osteoclast attachment to bone.

Fig. 5Adseverin knockout did neither affect the attachment nor the formation of sealing zone in vivo. **a, b**. Sealing zone structure in WT mice (**a**) and adseverin KO mice (**b**). **c** There was no significant difference of the attachment between WT and adseverin KO mice. *SZ* sealing zone, *RB* ruffled border, *B* bone. *Scale bar* 2 µm

Osteoclast Size {#Sec15}
---------------

Previous in vitro studies showed that osteoclasts generated from precursors derived from adseverin null mice were smaller \[[@CR12]\]. In the present study, we analyzed the size of osteoclasts formed in vivo and found that adseverin KO mice had significantly smaller osteoclasts (Fig. [6](#Fig6){ref-type="fig"}). Osteoclasts in WT mice were 274 ± 19 µm^2^, while osteoclasts in adseverin KO mice were less than half of this size (120 ± 13 µm^2^; *p* \< 0.001; Fig. [6](#Fig6){ref-type="fig"}a). Since osteoclast size is affected by cell fusion processes, the number of nuclei per cell was assessed. There was no difference in the numbers of nuclei per cell (Fig. [6](#Fig6){ref-type="fig"}b), indicating that adseverin does not affect the fusion of osteoclast precursor cells in normal bone in vivo. Further, consistent with their smaller size, osteoclasts from adseverin null mice exhibited smaller cytoplasmic area (Fig. [6](#Fig6){ref-type="fig"}c).

Fig. 6The size of osteoclasts and cytoplasm surface area were significantly decreased in adseverin KO mice in long bone. **a** Comparison of the size of osteoclasts between WT and adseverin KO mice (\*\*\**p* \< 0.001). **b** The number of nuclei per osteoclast was similar in adseverin KO mice. **c** Percentage of cytoplasm surface area was significantly reduced in adseverin KO mice (\*\*\**p* \< 0.001). Assessment of size was performed by Image-Pro Plus and the number of osteoclasts analyzed for the size was 63 for WT, and 134 for adseverin KO; for \# cytoplasm surface area 32 for WT and 42 for adseverin KO. **d, e** An example of an osteoclast in WT (**d**) and adseverin KO (**e**) mice. Osteoclasts are *encircled* by a *dashed line. N* nucleus, *B* bone. *Scale bar* 5 µm

Nuclear Size and Chromatin Distribution {#Sec16}
---------------------------------------

Overall assessment of the shapes of osteoclast nuclei in adseverin KO mice indicated marked differences between KO and wild-type mice (Fig. [7](#Fig7){ref-type="fig"}a--d). Osteoclast nuclei in WT mice were predominantly round or oval shaped with a smooth, nuclear membrane surface (Fig. [7](#Fig7){ref-type="fig"}a, c), while the nuclei of osteoclasts in adseverin KO mice exhibited prominent folds and indentations (Fig. [7](#Fig7){ref-type="fig"}b, d).

Fig. 7Nuclei of osteoclasts in adseverin knockout mice contained more heterochromatin and were smaller. **a--d** Nuclei of osteoclasts in WT (**a, c**) and adseverin KO mice (**b, d**). **a, b** *Scale bar* 5 µm; **c, d** *scale bar* 2 µm. **e** Percentage of heterochromatin was significantly higher in nuclei from adseverin KO mice. **f** Percentage of euchromatin was significantly lower in nuclei from adseverin KO mice. **g** The size of nuclei proved to be smaller in adseverin KO mice. Assessment of size was performed by Image-Pro Plus and the number of nuclei analyzed was 52 for WT and 67 for adseverin KO. *E* euchromatin, *H* heterochromatin, *Nu* nucleolus (\*\**p* \< 0.01, \*\*\**p* \< 0.001)

The spatial distributions of euchromatin and heterochromatin were affected by adseverin expression. The amount of heterochromatin, which is a tightly packed, electron-dense, transcriptionally inactive chromatin, was fourfold more abundant in osteoclast nuclei of adseverin KO mice (31 ± 3%) than WT mice (8 ± 1%) (Fig. [7](#Fig7){ref-type="fig"}e). Euchromatin, which is an electron-lucent, loosely packed transcriptionally active chromatin, showed the opposite distribution (Fig. [7](#Fig7){ref-type="fig"}f). Examination of nuclear size showed that osteoclast nuclei in adseverin KO mice were smaller than osteoclast nuclei in WT mice (Fig. [7](#Fig7){ref-type="fig"}g).

Discussion {#Sec17}
==========

Our findings indicate that the actin-capping/severing protein adseverin contributes to the maintenance of osteoclast size and nuclear chromatin organization. In the absence of adseverin expression, osteoclasts were smaller, and with reduced cytoplasmic area and nuclear size, suggesting that osteoclast structure is affected by adseverin-dependent regulation of the actin filament network. Indeed, previous studies indicated that actin filaments could control the volume \[[@CR25]\] and growth of cells \[[@CR26]\]. The actin cytoskeleton is a dynamic system that may serve as an interactive sensor in cell volume regulation to maintain actin filaments in equilibrium \[[@CR27]\]. Actin filament organization may be linked to the extent of cell swelling, by either regulation of ion transport systems or interactions of actin-associated proteins with discrete plasma membrane domains \[[@CR28]\]. Cantiello and colleagues suggested that interactions between actin and actin-severing/capping proteins influence the activity of Na^+^/K^+^ channels, which regulate the movement of water and affect cell volume \[[@CR29]\]. We propose that when adseverin is not expressed, the organization of actin cytoskeletal structures is affected, which in turn affects osteoclast size but, remarkably, not podosome structure. Evidently, the stability and turnover of actin filament structures in osteoclasts is under the control of multiple regulatory systems, one of which is adseverin.

The reduced size of osteoclasts in vivo in adseverin KO mice is consistent with previous in vitro studies showing that osteoclasts generated from precursor cells obtained from adseverin null mice were smaller \[[@CR11], [@CR12]\]. The smaller size of these osteoclasts was considered to be a result of the impaired fusion capacity of osteoclast precursors. Our current data show that the number of nuclei per osteoclast did not differ between adseverin null and wild-type littermates, indicating that fusion was not affected in vivo.

Although actin is one of the most abundant proteins in the cytoplasm, new data show a role for nuclear actin in cell function and structure \[[@CR30]--[@CR32]\]. While adseverin has not been demonstrated in the nucleus, gelsolin \[[@CR31]\] and the actin-capping protein CapG \[[@CR33]\] have been reported in the nucleus. Actin is present in cells in globular (G-actin), oligomeric, or filamentous form. In the nucleus, actin is mainly found as G-actin or oligomers \[[@CR34]\], which requires the action of severing proteins like gelsolin to generate short oligomers or monomers. Nuclear actin assembly can affect transcription \[[@CR35]\], suggesting an important relationship between the organization of actin filaments and transcriptional regulation. Consistent with this notion, we found that in the absence of adseverin the packing of heterochromatin was increased. Since heterochromatin is thought to be transcriptionally inactive because of a high proportion of repetitious sequences \[[@CR36], [@CR37]\], adseverin may regulate transcription and potentially histone assembly, which is reflected in chromatin packing. Adseverin, possibly in combination with actin, may play a previously unrecognized role in the organization of chromatin in osteoclast nuclei.

One of the most prominent sites of actin cytoskeletal organization in the osteoclast is at the sealing zone, where cells are firmly attached to the bone surface, which is a prerequisite for efficient bone degradation \[[@CR7]\]. While previous in vitro studies showed that adseverin affects podosome self-organization \[[@CR12]\], we found no differences in the structure of sealing zones of osteoclasts between WT and adseverin KO mice. Further, osteoclasts in adseverin KO mice formed a normal ruffled border and with no effect on bone resorption compared with WT mice. These data are in agreement with a previous study in which micro-CT showed an unchanged bone phenotype in healthy adseverin KO mice \[[@CR12]\]. We analyzed osteoclasts at different skeletal sites and compared normal bone with bone adjacent to sites with induced inflammation. The structure and function of osteoclasts from different skeletal sites can be quite different \[[@CR19]\]. In vitro studies showed that osteoclasts generated from precursors derived from alveolar bone and from long bone exhibit marked differences in cell shape \[[@CR20]\]. Here we found no measureable differences in osteoclasts at long bone and alveolar bone sites in WT and adseverin null conditional mice. Further studies are needed to elucidate this difference between in vitro and in vivo works.

Collectively, our findings indicate that although the actin-severing/capping protein, adseverin, does not contribute to bone metabolism in vivo, it plays an important role in the control of osteoclast size and in the organization of chromatin structure and nuclear size.
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